The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease

Journal of Clinical Gastroenterology

Volumn 46, Issue 8, 2012, Pages 662-668

  Hershcovici, Tiberiu ^a,b   Jha, Lokesh K ^a,b   Gadam, Rakshith ^a,b   Cui, Haiyan ^c   Gerson, Lauren ^d   Thomson, Stephen ^a   Fass, Ronnie ^a,b  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GERD; PPI failure; type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BODY MASS; COMORBIDITY; CORRELATIONAL STUDY; DISEASE DURATION; DRUG TREATMENT FAILURE; FEMALE; GASTROESOPHAGEAL REFLUX; GENDER; GLYCEMIC CONTROL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROGNOSIS;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84865529593     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31824e139b     Document Type: Article

References (43)

1. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983; 98:378-384.
2. Maser RE, Pfeifer MA, Dorman JS, et al. Diabetic autonomic neuropathy and cardiovascular risk Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med. 1990;150:1218-1222.
3. Lluch I, Ascaso JF, Mora F, et al. Gastroesophageal reflux in diabetes mellitus Am J Gastroenterol. 1999;94:919-924.
4. Murray FE, Lombard MG, Ashe J, et al. Esophageal function in diabetes mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol. 1987;82:840-843.
5. Bytzer P, Talley NJ, Hammer J, et al. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604-611.
6. Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: A population-based survey of 15,000 adults. Arch Intern Med. 2001;161:1989-1996.
7. Wang X, Pitchumoni CS, Chandrarana K, et al. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol. 2008;14:709-712.
8. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol. 1989;84:868-872.
9. Talley SJ, Bytzer P, Hammer J, et al. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001;96:1033-1038.
10. Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009;58:295-309.
11. Hershcovici T, Fass R. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol. 2010;26:367-378.
12. Huang C, Wang X. Increased use of proton pump inhibitors in patients with diabetes and neuropathy. Endocr Pract. 2009; 15:653-654.
13. Gallup Organization. The 2000 Gallup Study of Consumers' Use of Stomach Relief Products. Princeton: Gallup Organization; 2000.
14. Fass R, Shapiro M, Dekel R, et al. Systematic review: Protonpump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther. 2005;22:79-94.
15. Chey WD, Mody RR, Wu EQ, et al. Treatment patterns and symptom control in patients with GERD: US communitybased survey. Curr Med Res Opin. 2009;25:1869-1878.
16. Kase H, Hattori Y, Sato N, et al. Symptoms of gastroesophageal reflux in diabetes patients. Diabetes Res Clin Pract. 2008;79:e6-e7.
17. Horikawa A, Ishii-Nozawa R, Ohguro M, et al. Prevalence of GORD (gastro-oesophageal reflux disease) in Type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without. GORD Diabet Med. 2009;26:228-233.
18. Nishida T, Tsuji S, Tsujii M, et al. Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:258-265.
19. Jansson C, Nordenstedt H, Wallander MA, et al. Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: A population-based study. Aliment Pharmacol Ther. 2008;27:58-65.
20. Ruigomez A, Garcia Rodriguez LA, Wallander MA, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther. 2004;20:751-760.
21. El-Serag HB. Time trends of gastroesophageal reflux disease: A systematic review. Clin Gastroenterol Hepatol. 2007;5:17-26.
22. Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340-2348.
23. Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290:66-72.
24. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199-211.
25. Kang MS, Park DI, Oh SY, et al. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol. 2007;22:1656-1661.
26. Nam SY, Choi IJ, Ryu KH, et al. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology. 2010;139: 1902-1911 e2.
27. Sheu BS, Cheng HC, Chang WL, et al. The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis. Am J Gastroenterol. 2007;102:2387-2394.
28. Sellin JH, Chang EB. Therapy Insight: Gastrointestinal complications of diabetes - pathophysiology and management. Nat Clin Pract Gastroenterol Hepatol. 2008;5:162-171.
29. Spangeus A, El-Salhy M, Suhr O, et al. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients Scand. J Gastroenterol. 1999;34:1196-1202.
30. Ko GT, Chan WB, Chan JC, et al. Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus. Diabet Med. 1999;16:670-674.
31. Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 1994;32:637-641.
32. De Boer SY, Masclee AA, Lam WF, et al. Effect of acute hyperglycemia on esophageal motility and lower esophageal sphincter pressure in humans. Gastroenterology. 1992;103: 775-780.
33. Zhang Q, Horowitz M, Rigda R, et al. Effect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations. Am J Physiol Gastrointest Liver Physiol. 2004;286: G797-G803.
34. Rayner CK, Smout AJ, Sun WM, et al. Effects of hyperglycemia on cortical response to esophageal distension in normal subjects. Dig Dis Sci. 1999;44:279-285.
35. Yeap BB, Russo A, Fraser RJ, et al. Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care. 1996;19:880-882.
36. Thye-Ronn P, Sindrup SH, Arendt-Nielsen L, et al. Effect of short-term hyperglycemia per se on nociceptive and nonnociceptive thresholds. Pain. 1994;56:43-49.
37. De Block CE, De Leeuw IH. Current concepts in gastric motility in diabetes mellitus. Curr Diabetes Rev. 2006;2: 113-130.
38. Targownik LE, Metge C, Roos L, et al. The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use. Am J Gastroenterol. 2007;102:942-950.
39. Perkins AJ, Kroenke K, Unutzer J, et al. Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol. 2004;57:1040-1048.
40. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: A populationbased study. Am J Gastroenterol. 2002;97:2290-2299.
41. Kinekawa F, Kubo F, Matsuda K, et al. Esophageal function worsens with long duration of diabetes. J Gastroenterol. 2008;43:338-344.
42. Miller DR, Pogach L. Longitudinal approaches to evaluate health care quality and outcomes: The Veterans Health Administration diabetes epidemiology cohorts. J Diabetes Sci Technol. 2008;2:24-32.
43. Ried LD, Cameon R, Jia H, et al. Identifying veterans with acute strokes with high-specificity ICD-9 algorithm with VA automated records and Medicare claims data: A more complete picture. J Rehabil Res Dev. 2007;44:665-673.